TRDA Form 144: 25,907 RSUs Listed for Sale

TRDA notice of proposed sale of 25,907 restricted stock units.

Rhea-AI Filing Summary

TRDA notice of proposed sale of 25,907 restricted stock units. The filing lists the securities type as Restricted Stock Units with an award date of 03/01/2025. The filing also discloses prior sales in the past three months of 7,577 and 3,898 common shares, with proceeds shown as $89,078.24 and $45,442.49.

Key Figures

RSUs to be sold: 25,907 shares Recent sale 1: 7,577 shares Recent sale 2: 3,898 shares

3 metrics

RSUs to be sold 25,907 shares Restricted Stock Units with award date 03/01/2025

Recent sale 1 7,577 shares Sale date 03/03/2026, proceeds $89,078.24

Recent sale 2 3,898 shares Sale date 03/02/2026, proceeds $45,442.49

Key Terms

Restricted Stock Units, Form 144, Common

3 terms

Restricted Stock Units financial

"Restricted Stock Units | Issuer | 25907 | 03/01/2025"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Common financial

"Securities To Be Sold | Common | 03/01/2025"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does TRDA's Form 144 disclose about shares to be sold?

It lists 25,907 restricted stock units intended for sale. The form identifies the instrument as Restricted Stock Units with an award date of 03/01/2025 and labels the issuer as the selling party.

How many shares did the reporting person sell in the past three months for TRDA?

The filing shows sales of 7,577 and 3,898 common shares. Reported cash amounts for those sales are $89,078.24 and $45,442.49, respectively, with sale dates in March 2026.

What security type is being sold under the TRDA Form 144?

The filing specifies Restricted Stock Units converted to Common shares. The securities entry pairs the RSU award date 03/01/2025 with Common stock as the class to be sold.

Who is the reporting person named in the TRDA Form 144?

The report names Natarajan Sethuraman at One Design Center Place, Boston. That individual is listed with addresses and is associated with the disclosed recent sales of Common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/04/2026 - 04:32 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001873394
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ENTRADA THERAPEUTICS INC
SEC File Number	001-40969
Address of Issuer	One Design Center Place, Suite 17-500 Boston MASSACHUSETTS 02210
Phone	8575209158
Name of Person for Whose Account the Securities are To Be Sold	NATARAJAN SETHURAMAN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	25907	375651.50	38284313	05/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2025	Restricted Stock Units	Issuer			25907	03/01/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
NATARAJAN SETHURAMAN One Design Center Place, Suite 17-500 Boston MA 02210	Common	03/03/2026	7577	89078.24
NATARAJAN SETHURAMAN One Design Center Place, Suite 17-500 Boston MA 02210	Common	03/02/2026	3898	45442.49

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 03/01/2025 through 03/01/2026.
Date of Notice	05/04/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/18/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Natarajan Sethuraman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)